Showing 1–7 of 7
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Parent Roche (ROG.SW) group FY2025 revenue CHF 61.52bn (+2.0%); core operating margin 35.5%; net income CHF 13.80bn.
Diagnostics division sales CHF 13.85bn (+2% at constant exchange rates).
FY2025 revenue $6.80bn (+14.2%); operating margin 30.7%; net income $1.85bn.
Cash $3.92bn; debt $996.3m.
Parent Roche (ROG.SW) group FY2025 revenue CHF 61.52bn (+2.0%); core operating margin 35.5%; net income CHF 13.80bn.
Diagnostics division sales CHF 13.85bn (+2% at constant exchange rates).
FY2025 revenue €19.63bn (+1.5%); operating margin 9.3%; net income €978.0m.
Net debt €9.20bn.
Parent Fujifilm Holdings (4901.T) group FY2025 revenue ¥3.36tn (+5.0%); operating margin 10.4%; net income ¥276.7bn.
Group figures; Healthcare is one of several segments.
Listed (6702.T).
Latest full-year results not yet captured by HSH.